Factor This Power Engineering
Live Events
DTECH⢠Events
POWERGEN®
Calendar
Resource Center
Webinars
Podcasts
White Papers
Contribute Content
Solar
Utility Scale
Community
Residential
Wind Power
Turbines & Equipment
Offshore
Power Grid
Transmission
Outage Management
Grid Modernization
Smart Grids
Microgrids
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Pumped Storage
Long Duration
Business
Policy & Regulation
Project Development
Finance
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Utility Scale
Community
Residential
Wind Power
Turbines & Equipment
Offshore
Power Grid
Transmission
Outage Management
Grid Modernization
Smart Grids
Microgrids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Pumped Storage
Long Duration
Business
Policy & Regulation
Finance
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Resource Center
Webinars
Podcasts
Whitepapers
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
PMGC Holdings Inc. - Common Stock
(NQ:
ELAB
)
4.960
-0.020 (-0.40%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about PMGC Holdings Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
↗
November 01, 2024
Via
Benzinga
Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
↗
October 31, 2024
Via
Benzinga
12 Consumer Staples Stocks Moving In Friday's Intraday Session
↗
October 25, 2024
Via
Benzinga
Why Elevai Labs (ELAB) Stock Is Down 60% Today
↗
September 23, 2024
Elevai Labs shares are trading lower by 60% Monday morning. The company announced the pricing of an $8.0 million public offering.
Via
Benzinga
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity
October 22, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of Obesity
October 21, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
12 Consumer Staples Stocks Moving In Thursday's After-Market Session
↗
October 10, 2024
Via
Benzinga
Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred Stock
October 04, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
12 Consumer Staples Stocks Moving In Friday's After-Market Session
↗
October 04, 2024
Via
Benzinga
11 Consumer Staples Stocks Moving In Friday's Intraday Session
↗
October 04, 2024
Via
Benzinga
Why Phoenix Motor Shares Are Trading Higher By 150%; Here Are 20 Stocks Moving Premarket
↗
October 04, 2024
Via
Benzinga
12 Consumer Staples Stocks Moving In Thursday's After-Market Session
↗
October 03, 2024
Via
Benzinga
REPEAT: Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations
October 03, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Nasdaq Moves Lower; Levi Strauss Shares Slide
↗
October 03, 2024
Via
Benzinga
Crude Oil Jumps Over 4%; US Services PMI Revised Lower
↗
October 03, 2024
Via
Benzinga
Dow Dips Over 100 Points; US Jobless Claims Increase To 225,000
↗
October 03, 2024
Via
Benzinga
Topics
Stocks
12 Consumer Staples Stocks Moving In Thursday's Pre-Market Session
↗
October 03, 2024
Via
Benzinga
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations
October 03, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Launch of Clinical Study Combining Its Flagship Topical Exosome Skincare Products with a Medical Aesthetic Energy Device
October 02, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
7 Penny Stocks to Watch Now: ELAB, RJDG, BTTC, ATCH, CBDW, and More!
September 25, 2024
Via
AB Newswire
Dow Gains Over 50 Points; Elevai Labs Shares Plummet
↗
September 23, 2024
Via
Benzinga
Topics
Stocks
Crude Oil Down Over 1%; US Manufacturing PMI Falls In September
↗
September 23, 2024
Via
Benzinga
US Stocks Edge Higher; Chicago Fed National Activity Increases In August
↗
September 23, 2024
Via
Benzinga
Topics
Economy
Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering
September 23, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Results for E-Series Exosome Technology in Potential Melasma Applications
September 10, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Why GitLab Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
↗
September 04, 2024
Via
Benzinga
Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Encouraging Data Results Indicating Potential for Hair Restoration Using Proprietary Exosome Technology
September 03, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
12 Consumer Staples Stocks Moving In Monday's After-Market Session
↗
September 02, 2024
Via
Benzinga
Elevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Care Technology Utilizing YuvaBioⓇ Y100™ Mitochondrial Innovation and Elevai Exosomes™
August 28, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Data Results with Completion of Clinical Study of Elevai Enfinity™ Topical Exosome Serum
August 26, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
